Moleculin Biotech, Inc. (MBRX)

CIK 1659617 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Moleculin Biotech, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 20268-K0001437749-26-034926
Oct 30, 20268-K0001437749-26-034075
Oct 20, 20268-K0001437749-26-032969
Oct 16, 202640001437749-26-032864
Oct 16, 20268-K0001437749-26-032762
Oct 16, 202640001437749-26-032865
Oct 16, 202640001437749-26-032866
Oct 15, 2026S-80001437749-26-032730
Oct 9, 20268-K0001437749-26-032455
Oct 5, 20268-K0001437749-26-031978
Sep 29, 20268-K0001437749-26-031419
Sep 28, 20268-K0001437749-26-031280
Sep 25, 20268-K0001437749-26-031199
Sep 23, 20268-K0001437749-26-031005
Sep 18, 20268-K0001437749-26-030757
Sep 14, 20268-K0001437749-26-030315
Aug 31, 20268-K0001437749-26-029336
Aug 25, 2026SCHEDULE 13D0001437749-26-028927
Aug 25, 2026SCHEDULE 13D0001437749-26-028926
Aug 24, 2026DEFA14A0001437749-26-028842
Aug 24, 2026DEF 14A0001437749-26-028835
Aug 21, 2026424B50001437749-26-028751
Aug 14, 20268-K0001437749-26-027835
Aug 14, 2026PRE 14A0001437749-26-028049
Aug 13, 202610-Q0001437749-26-027688